...
首页> 外文期刊>American Journal of Pathology >Inhibition of Matrix Metalloproteinase Activity Attenuates Tenascin-C Production and Calcification of Implanted Purified Elastin in Rats
【24h】

Inhibition of Matrix Metalloproteinase Activity Attenuates Tenascin-C Production and Calcification of Implanted Purified Elastin in Rats

机译:基质金属蛋白酶活性的抑制减弱腱生蛋白-C的产生和大鼠植入的纯化的弹性蛋白酶的钙化。

获取原文
获取原文并翻译 | 示例
           

摘要

Elastin, a major extracellular matrix protein present in arterial walls provides elastic recoil and resilience to arteries. Elastin is prone to calcification in a number of cardiovascular diseases including atherosclerosis and bioprosthetic heart valve mineralization. We have recently shown that purified elastin when implanted subdermally in rats undergoes severe calcification. In the present study, we used this elastin implant model to investigate the molecular mechanisms underlying elastin calcification. Intense matrix metalloproteinase (MMP-2) and tenascin-C (TN-C) expression were seen in the proximity of the initial cal-cific deposits at 7 days. Gelatin zymography studies showed both MMP-2 (latent and active form) and MMP-9 expression within the implants. To investigate the role of MMPs in calcification, rats were administered a MMP inhibitor, (2S-allyl-N-hydroxy-3R-isobutyl-N-(1S-methylcarbamoyl-2-phenylethyl)-succinamide (BB-1101) by daily injection, either systemically or at the implant site. The site-specific BB-1101 administration almost completely suppressed TN-C expression, as shown by immunohistochemical staining, within the implants. The systemic BB-1101 injections also significantly reduced TN-C expression within the elastin implants. Moreover, calcification of elastin implants was significantly reduced in the site-specific administration group (5.43 ± 1.03 µg/mg Ca for BB-1101 group versus 21.71 ± 1.19 for control group, P < 0.001). Alizarin Red staining clearly showed that the elastin fibers were heavily calcified in the control group, whereas in BB-1101 group the calcification was scarce with few fibers showing initial calcification deposits. The systemic administration of BB-1101 also significantly reduced elastin calcification (28.07 ± 5.81 control versus 16.92 ± 2.56 in the BB-1101 group, P < 0.05), although less than the site-specific administration. Thus, the present studies indicate that MMPs and TN-C play a role in elastin-oriented calcification.
机译:弹性蛋白是存在于动脉壁中的主要细胞外基质蛋白,可为动脉提供弹性回弹力和弹性。弹性蛋白 在许多心血管疾病中都容易钙化,包括动脉粥样硬化和生物人工心脏瓣膜矿化。 我们最近发现,植入时纯化的弹性蛋白< sup> 大鼠皮下发生严重钙化。在当前的 研究中,我们使用该弹性蛋白植入模型来研究弹性蛋白钙化基础的 分子机制。在初始钙质矿床附近发现了强烈的 基质金属蛋白酶(MMP-2)和腱生蛋白-C(TN-C)表达 >在7天。明胶酶谱研究显示植入物内MMP-2(潜在的 和活性形式)和MMP-9的表达。为了研究MMP在钙化中的作用,向大鼠施用了一种MMP抑制剂(2S-烯丙基-N-羟基-3R-异丁基-N-(1S-甲基氨基甲酰基-通过全身或植入部位每天注射2-苯基乙基)-琥珀酰胺(BB-1101) 特定部位的BB-1101给药几乎完全抑制了 TN-C的表达,如免疫组织化学染色所示,在 植入物内。全身性BB-1101注射也显着 降低了弹性蛋白中的TN-C表达此外,定点给药组的 弹性蛋白植入物的钙化显着降低(BB-5.43±1.03 µg / mg Ca) 1101组与对照组的21.71±1.19 ,P <0.001)。茜素红染色清楚地显示 ,对照组的弹性蛋白钙化严重。 >组,而BB-1101组的钙化为sc arce ,几乎没有纤维显示出最初的钙化沉积物。 BB-1101的全身 给药也显着降低了弹性蛋白钙化 (对照组为28.07±5.81,而 BB-1101组为16.92±2.56,P <0.05),尽管少于特定于站点的 管理。因此,目前的研究表明MMPs 和TN-C在弹性蛋白定向钙化中起着作用。

著录项

  • 来源
    《American Journal of Pathology》 |2000年第3期|885-893|共9页
  • 作者单位

    From the Department of Bioengineering,Clemson University, Clemson, South Carolina;

    and the Division of Pediatric Cardiology Research,Children’s Hospital of Philadelphia and the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania;

    and the Division of Pediatric Cardiology Research,Children’s Hospital of Philadelphia and the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania;

    and the Division of Pediatric Cardiology Research,Children’s Hospital of Philadelphia and the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号